Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.67 |
| ▸ | TBXAS1 | P24557 | 5/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3033605 | 1.00 | AKR1C3 (0.67) | AKR1C3TBXAS1CYP19A1HTTALDH1A1 | |
| Hydrochloric Acid SCHEMBL1058186 | 0.98 | AKR1C3 (0.64) | AKR1C3TBXAS1CYP19A1HTTALDH1A1 | |
| Hydrochloric Acid SCHEMBL1058183 | 0.98 | AKR1C3 (0.64) | AKR1C3TBXAS1CYP19A1HTTALDH1A1 | |
| SCHEMBL2462984 | 0.89 | AKR1C3 (0.82) | AKR1C3TBXAS1HTTALDH1A1GLA | |
| SCHEMBL2462983 | 0.89 | AKR1C3 (0.82) | AKR1C3TBXAS1HTTALDH1A1GLA | |
| SCHEMBL10078746 | 0.88 | AKR1C3 (0.52) | AKR1C3TBXAS1CYP19A1HTTALDH1A1 | |
| SCHEMBL10976324 | 0.85 | CYP19A1 (0.47) | AKR1C3CYP19A1HTTALDH1A1GLA | |
| SCHEMBL10976321 | 0.85 | CYP19A1 (0.47) | AKR1C3CYP19A1HTTALDH1A1GLA | |
| SCHEMBL9065444 | 0.83 | AKR1C3 (0.45) | AKR1C3CYP19A1HTTALDH1A1GLA | |
| SCHEMBL9065442 | 0.83 | AKR1C3 (0.45) | AKR1C3CYP19A1HTTALDH1A1GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4748161-A | Triterpenyl esters of organic acids and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1988-05-31 | — | — | US | claimed |
| EP-0166542-A2 | Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1986-01-02 | — | — | EP | claimed |
| CN-115725216-B | Bottom anti-reflection coating composition and application thereof | 北京科华微电子材料有限公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-112384834-B | Cured film, alignment material, and retardation material | 日产化学株式会社 | 2023-08-11 | — | — | CN | disclosed |
| CN-115725216-A | Bottom anti-reflection coating composition and application thereof | 北京科华微电子材料有限公司 | 2023-03-03 | — | — | CN | disclosed |
| CN-114746512-A | Composition for forming cured film, alignment material, and phase difference material | 日产化学株式会社 | 2022-07-12 | — | — | CN | disclosed |
| CN-106980233-B | Cured film-forming composition, alignment material, and phase difference material | 日产化学工业株式会社 | 2021-07-13 | — | — | CN | disclosed |
| CN-112384834-A | Cured film, alignment material, and phase difference material | 日产化学株式会社 | 2021-02-19 | — | — | CN | disclosed |
| CN-107463066-B | Cured film-forming composition, alignment material, and phase difference material | 日产化学工业株式会社 | 2020-10-30 | — | — | CN | disclosed |
| CN-107463066-A | Form the composition, orientation material and phase difference material of cured film | 日产化学工业株式会社 | 2017-12-12 | — | — | CN | disclosed |
| US-9823400-B2 | Cured film formation composition, orientation material, and retardation material | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-11-21 | — | — | US | disclosed |
| CN-103842447-A | Cured film-forming composition, alignment material, and phase difference material | NISSAN CHEMICAL IND LTD | 2014-06-04 | — | — | CN | disclosed |
| US-7855300-B2 | Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2010-12-21 | — | — | US | disclosed |
| US-20100210591-A1 | BIS(TRIMETHYLSILYL)PHENYL COMPOUND OR SALT THEREOF, AND USE THEREOF | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2010-08-19 | — | — | US | disclosed |
| EP-2202235-A1 | BIS(TRIMETHYLSILYL)PHENYL COMPOUND OR SALT THEREOF, AND USE THEREOF | Taiho Pharmaceutical Co., Ltd. (JP) | 2010-06-30 | — | — | EP | disclosed |
| EP-0943601-B1 | Vinylcyclopropane-(meth)acrylates as well as their use | IVOCLAR VIVADENT AG (LI) | 2003-05-02 | — | — | EP | disclosed |
| EP-0943601-A1 | Vinylcyclopropane-(meth)acrylates as well as their use | IVOCLAR AG (LI) | 1999-09-22 | — | — | EP | disclosed |
| US-5264513-A | Dental adhesive | KABUSHIKI KAISHA SHOFU (JP) | 1993-11-23 | — | — | US | disclosed |
| US-4748161-A | Triterpenyl esters of organic acids and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1988-05-31 | — | — | US | disclosed |
| EP-0166542-A2 | Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1986-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100210591-A1 | BIS(TRIMETHYLSILYL)PHENYL COMPOUND OR SALT THEREOF, AND USE THEREOF | RARA, RARB, RXRA | AKR1C3 274/4885TBXAS1 1255/4885CYP19A1 968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.